ERTS Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,263
Closed -$540K 87
2023
Q2
$540K Sell
3,263
-9
-0.3% -$1.45K 0.13% 45
2023
Q1
$507K Sell
3,272
-589
-15% -$95.1K 0.12% 46
2022
Q4
$682K Sell
3,861
-23
-0.6% -$3.97K 0.18% 46
2022
Q3
$634K Sell
3,884
-37
-0.9% -$6.26K 0.18% 38
2022
Q2
$696K Sell
3,921
-64
-2% -$11.4K 0.2% 39
2022
Q1
$706K Sell
3,985
-586
-13% -$99.7K 0.2% 37
2021
Q4
$781K Buy
4,571
+21
+0.5% +$3.44K 0.19% 35
2021
Q3
$735K Hold
4,550
0.19% 35
2021
Q2
$750K Sell
4,550
-3
-0.1% -$497 0.2% 38
2021
Q1
$748K Buy
4,553
+517
+13% +$83.7K 0.22% 37
2020
Q4
$635K Sell
4,036
-16
-0.4% -$2.36K 0.21% 39
2020
Q3
$603K Sell
4,052
-105
-3% -$15.5K 0.23% 38
2020
Q2
$585K Buy
4,157
+44
+1% +$6.41K 0.24% 35
2020
Q1
$539K Buy
4,113
+1,825
+80% +$259K 0.26% 42
2019
Q4
$334K Hold
2,288
0.15% 62
2019
Q3
$296K Buy
+2,288
New +$301K 0.15% 63
2019
Q1
Sell
-946
Closed -$122K 207
2018
Q4
$122K Buy
+946
New +$132K 0.09% 100

Other funds holding JNJ

ERTS Wealth Advisors's JNJ Position: Q3 2023 in Review

ERTS Wealth Advisors sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 3,263 shares — an estimated $540K sold.

ERTS Wealth Advisors first reported a position in JNJ in Q4 2018 and held it in 17 quarters. The position peaked at $781K in Q4 2021. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • ERTS Wealth Advisors reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • ERTS Wealth Advisors sold 3,263 Johnson & Johnson shares in Q3 2023, an estimated $540K.
  • ERTS Wealth Advisors first reported a position in Johnson & Johnson in Q4 2018 and held it in 17 quarters.
  • ERTS Wealth Advisors's Johnson & Johnson position peaked at $781K in Q4 2021.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on ERTS Wealth Advisors's 13F filing for Q3 2023, filed 16 Oct 2023.